Fellowship · New Brunswick, NJ
Sponsored by Rutgers Health
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Eugenia Girda
Tumour extracellular vesicles and particles induce liver metabolic dysfunction.
Nature · 2023 · 239 citations · Constantinos Zambirinis
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
ESMO open · 2022 · 289 citations · Aliza Leiser, Eugenia Girda
Assessment of liver graft quality during hypothermic oxygenated perfusion: The first international validation study.
Journal of hepatology · 2025 · 53 citations · Guergana Panayotova
The psychological impacts of post-mastectomy breast reconstruction: a systematic review.
Annals of breast surgery : an open access journal to bridge breast surgeons across the world · 2024 · 48 citations · Tara Balija
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.
Nature medicine · 2025 · 59 citations ·
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Lancet (London, England) · 2025 · 49 citations · Aliza Leiser
Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation: A randomized, open-label, clinical trial.
Hepatology (Baltimore, Md.) · 2024 · 61 citations · Guergana Panayotova